Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance
In: Blood advances, Jg. 7 (2023), Heft 9, S. 1929-1943
Online
academicJournal
Zugriff:
Titel: |
Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance
|
---|---|
Autor/in / Beteiligte Person: | Naeem, A ; Utro, F ; Wang, Q ; Cha, JS ; Vihinen, M ; Martindale, S ; Zhou, YL ; Ren, Y ; Tyekucheva, S ; Kim, AS ; Fernandes, SM ; Saksena, G ; Rhrissorrakrai, K ; Levovitz, C ; Danysh, BP ; Slowik, K ; Jacobs, RA ; Davids, MS ; Lederer, JA ; Zain, R ; Smith, CIE ; Leshchiner, I ; Parida, L ; Getz, G ; Brown, JR |
Link: | |
Zeitschrift: | Blood advances, Jg. 7 (2023), Heft 9, S. 1929-1943 |
Veröffentlichung: | 2023 |
Medientyp: | academicJournal |
ISSN: | 2473-9537 (print) |
DOI: | 10.1182/bloodadvances.2022008447 |
Schlagwort: |
|
Sonstiges: |
|